Results 41 to 50 of about 283,903 (204)
, 2019 Supplemental Material, Supplemental-Materials-Venous-thromboembolism-in-NICU-REV1_(2) for Venous Thromboembolism in Neurocritical Care Patients by Tanuwong Viarasilpa, Nicha Panyavachiraporn, Jack Jordan, Seyed Mani Marashi, Meredith van Harn, Noel O ...
Jack Jordan (6679748) +7 more
core +1 more source
The use of imaging in the diagnosis and treatment of thromboembolic pulmonary hypertension
Cardiology JournalChronic thromboembolic pulmonary hypertension (CTEPH) is a potentially life-threatening condition, classified as group 4 pulmonary hypertension (PH), caused by stenosis or occlusion of the pulmonary arteries due to unresolved thromboembolic material. The
Konstantin Szewczuk +2 more
doaj +1 more source
Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism
Haematologica, 2016 Venous thromboembolism occurs frequently in cancer patients. Two variants in the factor 5 gene (F5), rs6025 encoding for the factor V Leiden mutation R506Q, and rs4524 encoding K858R, have been found to be associated with venous thromboembolism.
Olga V. Gran +9 more
doaj +1 more source
, 2019 Supplemental Material, Supplemental-Materials-Venous-thromboembolism-in-NICU-REV1 for Venous Thromboembolism in Neurocritical Care Patients by Tanuwong Viarasilpa, Nicha Panyavachiraporn, Jack Jordan, Seyed Mani Marashi, Meredith van Harn, Noel O ...
Jack Jordan (6679748) +7 more
core +1 more source
Development and validation of a risk prediction model for venous thromboembolism in postpartum women: A multinational cohort study [PDF]
, 2016 Objective To develop and validate a risk prediction model for venous thromboembolism in the first six weeks after delivery (early postpartum).Design Cohort study.Setting Records from England based Clinical Practice Research Datalink (CPRD) linked to ...
core +1 more source
Therapeutic Management of Septic Venous Thrombosis: A Narrative Review
Infectious Disease ReportsBackground/Objectives: Septic venous thrombosis is an uncommon complication but clinically significant due to its high morbidity and mortality and the complexity of therapeutic decision-making. The lack of standardized guidelines and the scarcity of high-
Anabel Franco-Moreno +3 more
doaj +1 more source
Forty-One-Year-Old Man with Pulmonary Embolism 5 Months After COVID-19
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2021 Background: Hypercoagulation is one of the striking features of COVID-19. Patients hospitalized with COVID-19 are at high risk for venous thromboembolism. However, it is unknown if the risk for venous thromboembolism persists after discharge.
Muhanad Taha +4 more
doaj +1 more source
Critical Care and Resuscitation, 2000 To review the recent advances in management of acute venous thromboembolism.Articles and published reviews on venous thromboembolism, pulmonary embolism and deep vein thrombosis.Acute venous thromboembolism describes a group of disorders that include venous thrombosis (usually deep vein thrombosis) and pulmonary thromboembolism. Ultrasound supplemented
M C, Atkinson, L I, Worthley
openaire +2 more sources
Haematologica, 2011 Background High-sensitivity C-reactive protein is associated with risk of arterial cardiovascular disease but conflicting results have been reported on its role in venous thromboembolic disease.
Erin M. Hald +6 more
doaj +1 more source
Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study. [PDF]
PLoS ONE, 2014 BACKGROUND: Elevated platelet count is associated with risk of venous thromboembolism in cancer patients initiating chemotherapy. It is not known whether this risk by platelet count is causal or merely reflects the malignant disease.
Hilde Jensvoll +3 more
doaj +1 more source